Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
4 pending office actions • 3 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Noxy Health Products Inc. has 5 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 4 examiners and 3 art units, so the portfolio presents several examination relationships rather than one unified examiner channel. Counsel may benefit from a common technical and claim framework that can be adapted to each assigned art unit.
GONG, KRIS HANYU is handling 2 of the pending matters and is the busiest examiner in the profile. That assignment provides a useful focus for identifying issues that may recur within the portfolio, while separate examiner positions still call for application-specific responses. Consistency in terminology and disclosure support should be balanced with the distinct examination settings.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (25%) |
| §102 only | 1 (25%) |
| Double-patenting only | 1 (25%) |
| Multi-statute (no §101) | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| EVANS, JASMINE AFIYA | 1 | 100.0% | +0.0% |
| MERCIER, MELISSA S | 1 | 72.1% | +5.8% |
| SASAN, ARADHANA | 1 | 64.6% | +26.0% |
| GONG, KRIS HANYU | 1 | 25.0% | +48.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18101713 | NITRIC OXIDE NASAL DELIVERY APPARATUS AND METHODS | GONG, KRIS HANYU | 86d overdue |
| 18667467 | Topical Pharmaceutical Skin Composition for the Delivery of Nitric Oxide in Combination with Other Topical Dermatologic Agents | EVANS, JASMINE AFIYA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18101713 | NITRIC OXIDE NASAL DELIVERY APPARATUS AND METHODS | GONG, KRIS HANYU | 86d overdue |
| 18349026 | NITRIC OXIDE FORMULATION DELIVERY DEVICE AND METHOD OF USE | SASAN, ARADHANA | — |
| Art Unit | Apps |
|---|---|
| 1615 | 2 |
| 1616 | 1 |
| 3785 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18667467 | Topical Pharmaceutical Skin Composition for the Delivery of Nitric Oxide in Combination with Other Topical Dermatologic Agents | EVANS, JASMINE AFIYA | 1616 | §102§103§112 | Non-Final OA | — | Pending | May 17, 2024 |
| 18506752 | Nitric Oxide Delivery Device for Healing Skin Wounds | MERCIER, MELISSA S | 1615 | §102 | Non-Final OA | — | Pending | Nov 10, 2023 |
| 18349026 | NITRIC OXIDE FORMULATION DELIVERY DEVICE AND METHOD OF USE | SASAN, ARADHANA | 1615 | DP | Final Rejection | — | Pending | Jul 07, 2023 |
| 18101713 | NITRIC OXIDE NASAL DELIVERY APPARATUS AND METHODS | GONG, KRIS HANYU | 3785 | §103 | Final Rejection | 86d overdue | Pending | Jan 26, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNoxy Health Products Inc. has 4 pending office actions as of October 2026, spread across 3 art units and 4 examiners.
Jasmine Afiya Evans has the most, with 1 of Noxy Health Products Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
